Cargando…
Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
Introduction: Substandard and falsified medicines undermine health systems. We sought to unravel the political and economic factors which drive the production of these products, and to explain how they reach patients. Methods: We conducted in-depth case studies in China, Indonesia, Turkey and Romani...
Autores principales: | Pisani, Elizabeth, Nistor, Adina-Loredana, Hasnida, Amalia, Parmaksiz, Koray, Xu, Jingying, Kok, Maarten Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518437/ https://www.ncbi.nlm.nih.gov/pubmed/31131333 http://dx.doi.org/10.12688/wellcomeopenres.15236.1 |
Ejemplares similares
-
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
por: Pisani, Elizabeth, et al.
Publicado: (2021) -
Why falsified medicines reach patients: an analysis of political and economic factors in Romania
por: Nistor, Adina-Loredana, et al.
Publicado: (2023) -
Substandard and Falsified Medicines in Myanmar
por: Sakuda, Mirai, et al.
Publicado: (2020) -
What Makes a National Pharmaceutical Track and Trace System Succeed? Lessons From Turkey
por: Parmaksiz, Koray, et al.
Publicado: (2020) -
Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia
por: Hasnida, Amalia, et al.
Publicado: (2021)